LifeX 2060 Longevity Income ETF (LFAW) seeks to provide income and capital appreciation by investing in companies positioned to benefit from increasing human longevity and demographic shifts toward an aging population. This thematic ETF targets the 'longevity economy' including healthcare innovation, senior services, and age-related consumer sectors.
How It Works
LFAW employs an actively managed approach to select companies across multiple sectors that derive significant revenue from longevity-related themes. The fund focuses on healthcare technology, pharmaceuticals, biotechnology, senior housing, financial services for retirees, and consumer goods targeting older demographics. Portfolio construction emphasizes fundamental analysis of companies' exposure to demographic trends, with quarterly rebalancing to capture emerging opportunities in the longevity space.
Key Features
- Targets the rapidly growing longevity economy driven by aging baby boomers and increasing life expectancy globally
- Offers 7.07% dividend yield, providing current income while participating in demographic-driven growth trends
- Recently launched in September 2024, representing a new thematic investment approach in an underserved market segment
Risks
- This ETF can lose value if longevity-themed companies underperform due to regulatory setbacks in healthcare or slower demographic transitions than expected
- Concentration in healthcare and age-related sectors creates vulnerability to sector-specific risks including drug approval failures and policy changes
- As a new fund with minimal assets, liquidity may be limited and tracking error could be higher during initial operating period
Who Should Own This
Best suited for investors with 10+ year time horizons seeking thematic exposure to demographic trends, willing to accept medium-to-high risk for potential growth. Appropriate as a satellite holding (5-15% allocation) for those believing in the longevity investment thesis. The dividend yield appeals to income-focused investors comfortable with sector concentration risk.